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Abstract
Background: This study was conducted to investigate factors associated with stroke in pa-
tients with paroxysmal atrial fibrillation (PAF) beyond CHADS2 score in terms of left ventricu-
lar (LV) diastolic function or left atrial (LA) function.
Methods: One hundred and sixty-one patients with PAF and age less than 75 (mean age 61 ±  
± 10; 69 male) who underwent transthoracic echocardiography were investigated. Patients 
were divided into two groups according to the stroke status (group 1 — no stroke vs. group 2 
— presence of stroke). Baseline echocardiographic parameters and LA segmental (4 segments: 
basal septal, lateral, inferior, and anterior) strain rate (SR) during normal sinus rhythm were 
analyzed.
Results: CHAD score (except S2) was similar between the two groups (0.6 ± 0.7 vs. 0.9 ± 0.7,  
p = 0.125). Patients with stroke had slightly lower body mass index (24.5 ± 2.7 vs. 23.4 ±  
± 2.4, p = 0.052). Echocardiographic parameters did not show any differences in both systolic 
and diastolic functions between the two groups, however elevated E/E’ ratio was noted (9.5 ± 
± 3.8 vs. 11.6 ± 3.9, p = 0.010) due to higher E velocity (63.5 ± 15.9 vs. 70.9 ± 16.0 cm/s,  
p = 0.046). In the analysis of LA SR, there are no differences of SR among the 4 segments. 
However, standard deviations (SD) of time to peak SR (SD of tA-SR) of the 4 segments were 
higher in patients with stroke (10.9 ± 9.9 vs. 22.1 ± 18.1 ms, p = 0.009) which indicates 
dyssynchronous contraction of LA. In multivariate analysis, SD of tA-SR (OR 1.074, CI 
1.024–1.128, p = 0.004) and elevated E/E’ (OR 1.189, CI 1.006–1.406, p = 0.048) were 
independently associated with stroke in patients with PAF.
Conclusions: Elevated E velocity, E/E’ and SD of tA-SR were associated with occurrence 
of stroke in patients with PAF even with similar CHAD scores. Increased SD of tA-SR and 
E/E’ were independently associated with stroke in patients with PAF. (Cardiol J 2016; 23, 
4: 429–436)
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Introduction
Atrial fibrillation (AF) is the most common 
arrhythmia occurring in 4% of the population aged 
60 or above [1, 2]. Problems associated with AF are 
not limited to heart failure (HF) but also include 
an increased risk of thromboembolic events [3]. 
Therefore, CHADS2 or CHA2DS2-VASc score is 
recommended for the assessment of thromboem-
bolic risk and treatment [3, 4]. When considering 
the mechanisms for AF [3], overlooking the left 
atrium (LA) in part of the assessment of thrombo-
embolism (TE) might be associated with remain-
ing risk of TE in patients with relatively low risk 
of TE measured by CHADS2 or CHA2DS2-VASc 
score. The LA serves multiple functions, acting 
as a reservoir during ventricular systole, as a con-
duit during early diastole, as an active contractile 
chamber that augments left ventricular (LV) filling 
in late diastole and as a suction source that refills 
itself in early systole [5]. In terms of atrial func-
tion, atrial size is regarded as a surrogate marker 
of function, with larger atria thought to represent 
a dysfunctional LA [6, 7]. Several other parameters 
may be useful including the peak velocity of the 
A wave and its velocity time integral obtained from 
transmitral Doppler flow [8, 9], atrial fraction [9, 
10], and atrial ejection force [10, 11]. In addition, 
A’ velocity using tissue Doppler imaging (TDI) 
for assessing global atrial function [12, 13] and 
segmental atrial function can be evaluated using 
color Doppler tissue imaging (CDTI) [12], as well 
as strain and strain rate (SR) imaging [14, 15]. 
Among them, atrial strain and SR using CDTI has 
been used to assess LA synchronicity in patients 
with AF [16, 17]. In addition, atrial synchrony and 
global strain in patients with paroxysmal AF (PAF) 
and its impact of pulmonary vein isolation by 3-di-
mensional strain echocardiograph and Kobayashi et 
al. [18] found that impaired LA function in patients 
with PAF and LA structural reverse remodeling 
occurred much earlier after pulmonary vein isola-
tion than the reversal of LA dyssynchrony. Patients 
with PAF are relatively younger, have a shorter 
AF history, less frequently experience valvular 
disease, HF, and diabetes mellitus than patients 
with sustained AF. Yet, the risk of TE does not 
differ between chronic or persistent AF [19].
Therefore, we aimed to investigate the fac-
tors associated with stroke in patients with PAF 
beyond CHADS2 score in terms of LA function and 
mechanics in South Korea.
Methods
Study design and participants
We conducted an observational cross-sectional 
study. In this study, we enrolled 161 patients with 
PAF who underwent echocardiography during 
normal sinus rhythm and normal LV systolic func-
tion at Kangnam Sacred Heart Hospital between 
January 2010 and January 2016 (59 ± 10 years, 113 
[72%] men). The primary endpoint of this study 
was the occurrence of ischemic stroke. Patients 
aged 75 or above, or with persistent long-standing, 
and permanent AF, concomitant significant arrhyth-
mia, AF associated with systemic diseases such 
as hyperthyroidism, hypoxemia, infection, etc., 
significant valvular diseases, pericardial diseases, 
myocardial diseases, or decreased LV systolic 
function (ejection fraction [EF] less than 50%) 
or pre-existing stroke at the time of diagnosis of 
PAF, or hemorrhagic stroke were excluded from 
the study. Enrolled patients were divided into two 
groups according to the occurrence of stroke after 
diagnosis of PAF: group 1: 138 patients without 
stroke vs. group 2: 79 patients with stroke. The 
participants underwent transthoracic echocardiog-
raphy and CDTI of the LA with zooming for strain 
and SR. We also collected baseline demographic 
and anthropometric data.
The study was approved by the Bioethical 
Committee of our University.
Transthoracic echocardiography
Transthoracic echocardiography was per-
formed using standard techniques with a 2.5-MHz 
transducer. The standard 2-dimensional and 
Doppler echocardiography was performed using 
a commercially available echocardiographic ma-
chine (Vivid 7R GE Medical System, Horten, Nor-
way). LV internal diameter (LVID), interventricular 
septal thickness (IVS), and ventricular inferolateral 
wall thickness (= posterior wall thickness, PWT) 
were measured at end-diastole according to the 
standards established by the American Society of 
Echocardiography [20]. LVEF was determined by 
the biplane Simpson’s method. Maximal LA volume 
was calculated using the prolate ellipsoid model and 
indexed to the body surface area (LA volume index 
[LAVI]). LV mass (LVM) was calculated using the 
linear method: LVM = 0.8·1 : 04·[(IVS + LVID + 
+ PWT)3 – LVID3] + 0.6 g. Thereafter, the LVM 
index was obtained using the following formula: 
LV mass/body surface area (BSA). LA volume was 
430 www.cardiologyjournal.org
Cardiology Journal 2016, Vol. 23, No. 4
measured by biplane method of disks and LAVI was 
calculated by LA volume indexed to BSA.
Conventional and tissue measurements
Mitral flow velocities were recorded in the 
apical 4-chamber view. Mitral inflow measurements 
included the E/A ratio and the peak early (E) and 
peak late (A) flow velocities. The tissue Doppler 
of the mitral annulus movement was also obtained 
from the apical 4-chamber view. A 1.5-mm sample 
volume was placed sequentially at the lateral and 
septal annular sites. Analysis was performed for 
early diastolic (E’) and late diastolic (A’) peak tis-
sue velocities. As a non-invasive parameter for LV 
stiffness, the LV filling index (E/E’) was calculated 
using the ratio of transmitral flow velocity to an-
nular velocity. Adequate mitral and TDI signals 
were recorded in all patients [21].
Left atrium strain and strain rate
Images were obtained using a narrow sector 
(frame rate > 110 fps) and attempts were made to 
align the atrial wall parallel to the Doppler beam 
[22]. Because of the thin atrial walls, a narrow 
(10 mm × 2 mm) sample volume was selected and 
placed in the middle of the septal and lateral walls 
of the atrium and in the annulus of the septal and 
lateral segments in apical 4-chamber view in zoom-
ing of LA (Fig. 1). The image was tracked frame 
by frame, ensuring in each frame that the sample 
volume was moved to its original location in the 
middle of the segment using dedicated software 
available on an offline measuring station (EchoPac 
PC, GE-Vingmed, Horten, Norway). Figure 2 
shows images of atrial SR (A — synchronous LA, 
B — dyssynchronous LA). The vertical red line 
denotes aortic valve closure (AVC). The horizontal 
shift arrow denotes the time from AVC to peak 
A-SR (tA-SR).
Statistical analysis
Continuous variables were analyzed using 
Student’s t-test and dichotomous variables were 
analyzed using the c2 test. In addition, multivari-
ate analysis (logistic and linear regression, SPSS 
for Macintosh, version 23, SPSS, Inc., Chicago, 
Ill, USA) was performed. All variables that had 
a p value £ 0.05 were considered statistically 
significant.
Results
Baseline demographic characteristics  
and echocardiographic parameters
Table 1 shows baseline demographic charac-
teristics of the patient population. In our study, 
23 (14%) patients with PAF had a stroke with 
similar CHADS2 score (except S2) (0.6 ± 0.7 vs. 
Figure 1. Left atrial walls, a narrow (10 mm × 2 mm) sample volume is selected and placed in the middle of the septal 
and lateral walls of the atrium and in the annuls of the septal and lateral segments in apical 4-chamber view in zoom-
ing of left atrium (LA); AML — anterior mitral leaflet; PML — posterior mitral leaflet; RUPV and LUPV — right and left 
pulmonary vein.
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0.9 ± 0.7, p = 0.125). Patients with stroke had 
a slightly lower body mass index (24.5 ± 2.7 vs. 
23.4 ± 2.4, p = 0.052). Otherwise, blood pressure 
was similar in both groups.
Table 2 shows echocardiographic parameters 
of the patient population. Cardiac size was similar 
in both groups, especially LA size represented as 
LAVI measured by biplane Simpson’s method even 
smaller in patients with stroke (LAVI: 26.5 ± 9.2 
vs. 25.3 ± 8.9 mL/m2, p = 0.534); there was no dif-
ference in terms of LV systolic function. However, 
patients with stroke had more elevated E/E’ (9.5 ± 
± 3.8 vs. 11.6 ± 3.9, p = 0.010) due to higher E ve-
locity (63.5 ± 15.9 vs. 70.6 ± 19.0 cm/s, p = 0.046).
Analysis of LA strain rate
Strain rate of the 4 segments of LA did not dif-
fer between the two groups, as shown in Table 3. 
However, standard deviation (SD) of time to 
peak atrial SR was significantly increased in pa-
Table 1. Baseline demographic characteristics.
Variables Group 1 (n = 138) Group 2 (n = 23) P 
Age [years] 59 ± 10 62 ± 9 0.137
Women 44 (32%) 4 (18%) 0.219
Body mass index [kg/m2] 24.5 ± 2.7 23.4 ± 2.4 0.052
C-SBP [mm Hg] 130 ± 22 139 ± 22 0.330
C-DBP 76 ± 10 78 ± 10 0.656
B-SBP 124 ± 18 136 ± 29 0.167
B-DBP 74 ± 16 72 ± 13 0.618
Pulse rate [bpm] 69 ± 13 71 ± 16 0.608
CHAD score 0.6 ± 0.7 0.9 ± 0.7 0.125
Current medications:
Aspirin 43 (31%) 7 (30%) 1.000
Clopidogrel 9 (7%) 1 (6%) 1.000
Oral anticoagulation 3 (2%) 3 (13%) 0.038
ACEI or ARBs 40 (29%) 9 (39%) 0.336
Beta-blockers 21 (15%) 2 (9%) 0.534
Calcium channel blockers 37 (27%) 10 (44%) 0.136
Statins 35 (25%) 7 (32%) 0.486
C — central; B — brachial; SBP — systolic blood pressure; DBP — diastolic blood pressure; ACEI — angiotensin converting enzyme inhibitor; 
ARB — angiotensin receptor blocker
Figure 2. Color tissue Doppler image of left atrium (LA) in a patient without stroke (A) and a patient with stroke (B); 
AVC — aortic valve closure; tA-SR — time from AVC to peak A-SR.
A B
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tients with stroke (10.9 ± 9.9 vs. 22.1 ± 18.1 ms, 
p = 0.009), which represents dyssynchronous LA 
contraction during LV diastole. Figure 2 shows the 
difference in TDI of the LA in a patient without 
stroke (Fig. 2A) and with stroke (Fig. 2B). Figure 2A 
shows synchronous atrial contraction and Figure 2B 
shows dyssynchronous atrial contraction during 
diastole.
Table 2. Baseline echocardiographic findings.
Variables Group 1 Group 2 P
Indexed LA volume [mL/m2] 26.5 ± 9.2 25.3 ± 8.9 0.534
LV mass index [g/m2] 91.0 ± 24.4 97.2 ± 25.0 0213
Diastolic IVSWT [mm] 9.4 ± 1.6 9.3 ± 2.1 0.936
Systolic IVSWT [mm] 12.9 ± 2.0 12.8 ± 2.5 0.187
Diastolic LVPWT [mm] 8.8 ± 1.5 9.3 ± 1.8 0.185
Systolic LVPWT [mm] 12.7 ± 1.9 13.4 ± 2.5 0.099
LV end-diastolic dimension [mm] 50.3 ± 3.9 49.7 ± 4.7 0.642
LV end-systolic dimension [mm] 32.7 ± 3.7 32.1 ± 4.1 0.504
LV ejection fraction [%] 64.1 ± 6.3 66.1 ± 5.4 0.610
Peak E wave velocity [cm/s] 63.5 ± 15.9 70.6 ± 19.0 0.046
Peak A wave velocity [cm/s] 68.5 ± 19.0 72.7 ± 20.2 0.321
E/A ratio 1.0 ± 0.5 1.1 ± 0.5 0.312
Deceleration time [ms] 198.6 ± 41.8 184.6 ± 34.9 0.124
Septal peak E’ velocity [cm/s] 7.1 ± 2.3 6.6 ± 2.3 0.298
Septal peak A’ velocity [cm/s] 8.8 ± 2.3 8.2 ± 2.4 0.227
Septal E’/A’ ratio 1.0 ± 1.1 0.8 ± 0.4 0.606
Septal E/E’ ratio 9.5 ± 3.8 11.6 ± 3.9 0.010
Septal peak S’ velocity [cm/s] 7.4 ± 1.5 7.2 ± 1.8 0.479
Estimated RVSP [mm Hg] 29.6 ± 6.0 29.5 ± 8.0 0.910
LA — left atrial; IVSWT — interventricular septal wall thickness; LVPWT — left ventricular posterior wall thickness; LV — left ventricular;  
RVSP — right ventricular systolic pressure
Table 3. Analysis of left atrial strain.
Variables Group 1 Group 2 P
Basal septal E-SR [S–1] –3.9 ± 2.3 –2.9 ± 2.4 0.066
Basal septal A-SR [S–1] –4.5 ± 2.3 –4.1 ± 3.0 0.579
Septal tA-SR [ms] 754 ± 218 703 ± 209 0.313
Basal lateral E-SR [S–1] –5.2 ± 3.2 –3.3 ± 2.1 0.009
Basal lateral A-SR [S–1] –5.1 ± 2.6 –4.8 ± 3.9 0.710
Lateral tA-SR [ms] 766 ± 218 724 ± 204 0.404
Basal inferior E-SR [S–1] –3.5 ± 2.3 –2.0 ± 1.6 0.001
Basal inferior A-SR [S–1] –3.8 ± 2.2 –3.1 ± 2.7 0.218
Inferior tA-SR [ms] 763 ± 217 724 ± 209 0.443
Basal anterio E-SR [S–1] –3.1 ± 2.0 –2.5 ± 2.1 0.175
Basal anterior A-SR [S–1] –3.2 ± 1.8 –2.7 ± 1.7 0.267
Anterior tA-SR [ms] 760 ± 217 709 ± 208 0.288
SD of tA-SR [ms] 10.9 ± 9.9 22.1 ± 18.1 0.009
A-SR — peak atrial strain rate in late diastole; tA-SR — duration from aortic valve closure to peak atrial strain rate; E-SR — peak early diastolic 
strain rate; SD — standard deviation
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Table 4. Factors associated with stroke.
Variables Odds ratio 95% confidence interval P
Univariate analysis
E 1.026 1.000-1.054 0.051
E/E’ 1.157 1.029-1.031 0.015
SD of tA-SR [ms] 1.071 1.025-1.119 0.002
Multivariate analysis
E 1.029 0.991-1.068 0.132
E/E’ 1.189 1.006-1.406 0.048
SD of tA-SR [ms] 1.074 1.023-1.128 0.004
tA-SR — duration from aortic valve closure to peak atrial strain rate; SD — standard deviation
Factors associated with stroke  
in patients with PAF
In an univariate analysis, elevated E velo city 
of mitral inflow, elevated E/E’ ratio, and increased 
SD of time to peak atrial contraction during dias-
tole were associated with occurrence of stroke 
in patients with PAF. Among them, increased 
SD of time to peak atrial contraction (OR 1.074, 
CI 1.024–1.128, p = 0.004) and elevated E/E’ ratio 
(OR 1.189, CI 1.006–1.406, p = 0.048) were inde-
pendently associated with occurrence of stroke in 
patients with PAF in multivariate analysis (Table 4).
Discussion
This study aimed to find echocardiographic 
or other factors associated with occurrence of 
stroke in patients with PAF and low CHADS2 score. 
Therefore, we selected patients aged 74 or less 
without congestive HF. We found that 23 (14%) 
sample patients with PAF had a stroke in this study, 
despite similar CHADS2 score when compared to 
patients without stroke. Elevated E velocity of mi-
tral inflow, elevated E/E’ ratio, and increased SD of 
time to peak atrial contraction during diastole were 
associated with occurrence of stroke. Among them, 
increased SD of time to peak atrial contraction and 
elevated E/E’ ratio were independently associated 
with occurrence of stroke in patients with PAF.
There were no significant differences in de-
mographic factors between the two groups. Due 
to the fact that we enrolled subjects who had 
a relatively low risk of TE, the study subjects had 
low CHADS2 score (except stroke) regardless of 
the presence of stroke.
In terms of echocardiographic parameters, LA 
size presented as LAVI was similar between the 
two groups, even slightly smaller in patients with 
stroke. It is well known that increased LA size is 
associated with occurrence of AF [23, 24], and LA 
enlargement is associated with poor prognosis and 
cardiovascular events, such as cerebral infarction 
and HF, as well as adverse overall outcomes [25, 
26]. However, LA size was not associated with the 
occurrence of stroke in patients with PAF and they 
had low risk for TE, according to our study. E/E’ 
ratio was elevated in patients with stroke due to 
elevated E velocity of mitral inflow in our study, 
but the values were within normal limits without 
clinical significance. However, when consider-
ing LA function, as opposed to size, there was 
a significant difference between the two groups. 
Atrial size is also regarded as a surrogate marker 
of function, with larger atria thought to represent 
a dysfunctional LA [6, 7]. However, our study sug-
gests that patients who do not have mitral valve 
disease or other systemic diseases show normal 
LA size, even though they had a documented PAF. 
In addition, LA size was not associated with the 
occurrence of stroke. Among several parameters 
assessing LA function, atrial strain and SR using 
CDTI has been used to assess LA synchronicity 
in patients with AF [16, 17]. Dell’Era et al. [16] 
reported a change of atrial asynchrony and func-
tion before and after electrical cardioversion for 
persistent AF and predictive value of data of LA 
mechanics before cardioversion for recurrence of 
AF. Likewise, there was a significant difference in 
LA synchronicity between the two groups in our 
study. Patients who had a stroke showed increased 
SD of time to peak atrial contraction during dias-
tole, suggesting LA dyssynchrony. Kuppahally et 
al. [17] explained that LA wall fibrosis measured by 
delayed-enhancement magnetic resonance imaging 
is inversely related to LA strain and SR, and that 
these are related to the AF burden. Furthermore, 
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they suggested that echocardiographic assessment 
of LA structural and functional remodeling is quick 
and feasible, and may be helpful in predicting out-
comes in AF [17].
Limitations of the study
This study had several limitations. First of 
all, current guideline recommends CHA2DS2-VASc 
score to discriminate a very low risk of TE in pa-
tients with AF, not CHADS2 score [4]. Checking 
for aortic plaque or peripheral vascular disease is 
not always possible as some patients refuse further 
evaluation. For this reason, CHADS2 score is still 
widely used in daily clinical practice. Secondly, 
we did not perform cardiac magnetic resonance 
imaging as Kuppahally et al. [17], therefore we 
could not clarify the mechanism of LA dyssyn-
chronicity. Thirdly, the sample size was small, thus 
further study is recommended. In addition, we only 
measured LA function in one apical view, more 
detailed analysis could be useful in future stud-
ies. Lastly, we did not perform transesophageal 
echocardiography (TEE) in all patients who had 
stroke to assess whether the LA was the source 
of stroke. This was because many patients refused 
TEE. Therefore, correlation between the TEE 
and LA dyssynchronicity would be necessary in 
further studies.
Clinical implications
Although this study had several limitations, 
it did show that both CHADS2 score and LA size 
were not good predictors for occurrence of stroke 
in patients with PAF and low risk TE. LA func-
tion measured by atrial strain and SR using CDTI 
revealed that dyssynchronous LA was associated 
with stroke. Therefore, we recommend routine 
analysis of LA strain and SR using CDTI and cal-
culation of synchronicity in patients with PAF. If 
dyssynchronous LA was detected, further evalu-
ations to estimate CHA2DS2-VASc score and/or 
a more aggressive oral anti-coagulation therapy 
could be considered for those patients.
Conclusions
Fourteen percent of the sample patients with 
PAF had stroke in this study, although they had 
similar CHADS2 score compared to patients with-
out stroke. Elevated E velocity of mitral inflow, 
elevated E/E’ ratio, and increased SD of time to 
peak atrial contraction during diastole were associ-
ated with the occurrence of stroke. Among them, 
increased SD of time to peak atrial contraction 
suggesting dyssynchronous LA was independently 
associated with occurrence of stroke in patients 
with PAF.
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